Lv1
60 积分 2020-11-01 加入
Metabolic dysfunction-associated steatotic liver disease (MASLD). Assessing metabolic dysfunction, cardiovascular risk factors, and lifestyle habits
19天前
已关闭
Gut-derived indole propionic acid alleviates liver fibrosis by targeting profibrogenic macrophages via the gut‒liver axis
27天前
已完结
A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesis
1个月前
已完结
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis
2个月前
已完结
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
2个月前
已完结
Cyclophosphamide and Cyclosporin for GVHD Prevention
2个月前
已完结
Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
3个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
3个月前
已完结
Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review
3个月前
已关闭
Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis
3个月前
已完结
皖公网安备34019202002308
